...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Sincerely,

George et al

Message: DSMB 5 postitive recomendation

Brief text:

 
BRIEF-Resverlogix announces fifth positive recommendation from Data Safety Monitoring Board for Apabetalone
2017-11-01 08:41:08 AM ET (Reuters)
   
   

Nov 1 (Reuters) - Resverlogix Corp

* Resverlogix announces fifth positive recommendation from Data Safety Monitoring Board for phase 3 study of Apabetalone

* Resverlogix - ‍independent DSMB recommended phase 3 study of Apabetalone should continue as planned without modifications ​

* Resverlogix Corp - ‍full enrollment for phase 3 study of apabetalone now anticipated in first half of 2018​ Source text for Eikon: Further company coverage: ([email protected])

Share
New Message
Please login to post a reply